Engineering virus-like particles for lymph-node targeted cancer immunotherapy: strategies, challenges, and future prospects
{{output}}
Virus-like particles (VLPs) are emerging as effective platforms for cancer immunotherapy because of their strong immunogenicity and structural similarity to viruses. This review highlights recent advancements in engineering VLPs to target lymph nodes (LNs) by ... ...
